beta Amyloid Antikörper (AA 1-42)
-
- Target Alle beta Amyloid (Abeta) Antikörper anzeigen
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
-
Bindungsspezifität
- AA 1-42
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser beta Amyloid Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Produktmerkmale
- Serum
- Isotyp
- IgG
- Top Product
- Discover our top product Abeta Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
-
-
Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study." in: Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences, Vol. 46, Issue 4, pp. 255-70, (2009) (PubMed).
: "Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice." in: Journal of neuroinflammation, Vol. 3, pp. 11, (2006) (PubMed).
: "
-
Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study." in: Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences, Vol. 46, Issue 4, pp. 255-70, (2009) (PubMed).
-
- Target
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
- Andere Bezeichnung
- beta AMYLOID (Abeta Produkte)
- Gen-ID
- 351
- UniProt
- P05067
- Pathways
- Inflammasome
-